Evidence map›Paper›PMID 30919264›Full record

ArticleJournal of gastrointestinal cancer2020

The First Screening Program for Colorectal Cancer in the North of Iran.

Hossein-Ali Nikbakht, Javad Shokri-Shirvani, Hassan Ashrafian-Amiri, Haleh Ghaem, Ali Jafarnia, Sedigheh Alijanpour, Seyed-Mostaffa Mirzad, Soheil Hassanipour

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of gastrointestinal cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Hossein-Ali NikbakhtSocial Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Javad Shokri-ShirvaniGastroenterology Department. Rohani Hospital, Babol University of Medical Sciences, Babol, Iran.
Hassan Ashrafian-AmiriSocial Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Haleh GhaemResearch Center for Health Sciences, Department of Epidemiology, School of Health, Shiraz University of Medical Sciences, Shiraz, Iran. halehghaem.epid@gmail.com.
Ali JafarniaSocial Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Sedigheh AlijanpourSocial Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Seyed-Mostaffa MirzadSocial Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Soheil HassanipourGI Cancer Screening and Prevention Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Babol University of Medical Sciences · IRGuilan University of Medical Sciences · IRShiraz University of Medical Sciences · IR

Funding

Shiraz University of Medical Sciences : 95-01-42-13948
6 · The paper itself

Abstract

purposeColorectal cancer (CRC) is the second leading cause of cancer deaths. This screening aimed to determine the positivity of the fecal occult blood test (FOBT) and the results of colonoscopy among a medium-risk population in the northern regions of Iran.

methodsThis cross-sectional study was conducted in 2016 on 924 eligible samples from people over the age of 50. After completing the questionnaire, participants were referred to a laboratory for three immunochemical fecal occult blood tests (IFOBTs). If the result of at least one test was found to be positive, they were submitted to the state hospital for colonoscopy. Results were recorded according to the number of people with CRC, polyps, and other diseases.

resultsAmong a total number of 897 (97.1%) cases, at least two acceptable samples were sent to the laboratory and in 229 (25.5%) cases, at least one case was IFOBT-positive. Finally, 118 (64.1%) cases were referred to the hospital for colonoscopy; among these, 5 colonoscopies were incomplete, while 113 had complete colonoscopies with 42 healthy subjects, 3 cases of cancer, 28 cases of polyps, and other diseases identified in the remaining patients.

conclusionsBased on the results, the prevalence of positive IFOBT, polyps, and cancer was high. The results of this study will play an important role in establishing a CRC screening program in the country. With reference to the status of the general population, the target group in the country should be reviewed and not limited to the first-degree relatives of patients.

Indexed as

Colorectal NeoplasmsCross-Sectional StudiesEarly Detection of CancerFemaleHumansMaleMiddle AgedColonoscopyColorectal cancerFecal occult blood testPolypsScreening

Identifiers

PMID30919264
OpenAlexW2931562273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.